(VIANEWS) – Atmos Energy Corporation (ATO), The Ensign Group (ENSG), Axcelis Technologies (ACLS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Atmos Energy Corporation (ATO)
23.4% sales growth and 8.65% return on equity
Atmos Energy Corporation, together with its subsidiaries, engages in the regulated natural gas distribution, and pipeline and storage businesses in the United States. It operates in two segments, Distribution, and Pipeline and Storage. The Distribution segment is involved in the regulated natural gas distribution and related sales operations in eight states. This segment distributes natural gas to approximately three million residential, commercial, public authority, and industrial customers. As of September 30, 2020, it owned 71,558 miles of underground distribution and transmission mains. The Pipeline and Storage segment engages in the pipeline and storage operations. This segment transports natural gas for third parties and manages five underground storage reservoirs in Texas; and provides ancillary services to the pipeline industry, including parking arrangements, lending, and inventory sales. As of September 30, 2020, it owned 5,684 miles of gas transmission lines. Atmos Energy Corporation was founded in 1906 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Atmos Energy Corporation has a trailing twelve months EPS of $5.76.
PE Ratio
Atmos Energy Corporation has a trailing twelve months price to earnings ratio of 21.23. Meaning, the purchaser of the share is investing $21.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.65%.
Moving Average
Atmos Energy Corporation’s value is above its 50-day moving average of $117.58 and higher than its 200-day moving average of $114.03.
2. The Ensign Group (ENSG)
19.1% sales growth and 19.16% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $4.11.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 23.97. Meaning, the purchaser of the share is investing $23.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.16%.
Moving Average
The Ensign Group’s value is above its 50-day moving average of $92.28 and higher than its 200-day moving average of $92.59.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 13.5% and 16.4%, respectively.
Volume
Today’s last reported volume for The Ensign Group is 341271 which is 23.95% above its average volume of 275324.
3. Axcelis Technologies (ACLS)
16.2% sales growth and 30% return on equity
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Earnings Per Share
As for profitability, Axcelis Technologies has a trailing twelve months EPS of $5.78.
PE Ratio
Axcelis Technologies has a trailing twelve months price to earnings ratio of 33.95. Meaning, the purchaser of the share is investing $33.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30%.
Sales Growth
Axcelis Technologies’s sales growth is 16.1% for the current quarter and 16.2% for the next.
Moving Average
Axcelis Technologies’s worth is way above its 50-day moving average of $172.21 and way above its 200-day moving average of $119.86.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Axcelis Technologies’s EBITDA is 73.26.
Yearly Top and Bottom Value
Axcelis Technologies’s stock is valued at $196.21 at 16:22 EST, below its 52-week high of $201.00 and way higher than its 52-week low of $49.78.
Previous days news about Axcelis Technologies(ACLS)
- According to Zacks on Friday, 11 August, "This calls for investing in stocks such as Atmos Energy (ATO Quick QuoteATO – Free Report) , TopBuild (BLD Quick QuoteBLD – Free Report) , Axcelis Technologies (ACLS Quick QuoteACLS – Free Report) and Comstock Inc. (LODE Quick QuoteLODE – Free Report) that are poised to make the most of the likely pause in interest rate hikes."
4. Compania Cervecerias Unidas, S.A. (CCU)
14.4% sales growth and 9.09% return on equity
CompañÃa CervecerÃas Unidas S.A. operates as a beverage company principally in Chile, Argentina, Uruguay, Paraguay, Colombia, and Bolivia. The company operates through three segments: Chile, International Business, and Wine. It produces and sells alcoholic and non-alcoholic beer under proprietary and licensed brands, as well as distributes Pernod Ricard products in non-supermarket retail stores. The company also produces and sells non-alcoholic beverages, including carbonated soft drinks, nectars and juices, sports and energy drinks, and ice tea, as well as mineral, purified, and flavored bottled water, as well as ready-to-mix products with instant powder drinks. In addition, it is involved in the production and distribution of pisco, cocktails, rum, flavored alcoholic beverages, wine, cider, and spirits. The company serves small and medium-sized retail outlets; retail establishments, such as restaurants, hotels, and bars; wholesalers; and supermarket chains. It also exports its products to Europe, Latin America, the United States, Canada, Asia, Oceania, and internationally. The company was founded in 1850 and is based in Santiago, Chile. CompañÃa CervecerÃas Unidas S.A. is a subsidiary of Inversiones y Rentas S.A.
Earnings Per Share
As for profitability, Compania Cervecerias Unidas, S.A. has a trailing twelve months EPS of $0.73.
PE Ratio
Compania Cervecerias Unidas, S.A. has a trailing twelve months price to earnings ratio of 23.08. Meaning, the purchaser of the share is investing $23.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.09%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Compania Cervecerias Unidas, S.A.’s EBITDA is 0.04.
Volume
Today’s last reported volume for Compania Cervecerias Unidas, S.A. is 96647 which is 27.05% below its average volume of 132488.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 19, 2023, the estimated forward annual dividend rate is 0.31 and the estimated forward annual dividend yield is 1.84%.
Yearly Top and Bottom Value
Compania Cervecerias Unidas, S.A.’s stock is valued at $16.85 at 16:22 EST, under its 52-week high of $17.74 and way above its 52-week low of $9.31.
5. iRadimed Corporation (IRMD)
12.8% sales growth and 21.67% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Earnings Per Share
As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.06.
PE Ratio
iRadimed Corporation has a trailing twelve months price to earnings ratio of 45.68. Meaning, the purchaser of the share is investing $45.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.67%.
Sales Growth
iRadimed Corporation’s sales growth is 20% for the current quarter and 12.8% for the next.
Volume
Today’s last reported volume for iRadimed Corporation is 14886 which is 57.22% below its average volume of 34798.
Yearly Top and Bottom Value
iRadimed Corporation’s stock is valued at $48.42 at 16:22 EST, below its 52-week high of $51.04 and way higher than its 52-week low of $26.00.
6. Ambev (ABEV)
10.3% sales growth and 16.92% return on equity
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.
Earnings Per Share
As for profitability, Ambev has a trailing twelve months EPS of $0.19.
PE Ratio
Ambev has a trailing twelve months price to earnings ratio of 15.32. Meaning, the purchaser of the share is investing $15.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.92%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 19, 2022, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 4.98%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 82.71B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ambev’s EBITDA is 0.54.
Yearly Top and Bottom Value
Ambev’s stock is valued at $2.91 at 16:22 EST, way below its 52-week high of $3.24 and way above its 52-week low of $2.40.
7. Texas Capital Bancshares (TCBI)
9.6% sales growth and 12.02% return on equity
Texas Capital Bancshares, Inc. operates as the bank holding company for Texas Capital Bank, National Association that provides various banking products and services for commercial businesses, and professionals and entrepreneurs. It offers business deposit products and services, including commercial checking accounts, lockbox accounts, and cash concentration accounts, as well as other treasury management services, including information services, wire transfer initiation, ACH initiation, account transfer, and service integration; and consumer deposit products, such as checking accounts, savings accounts, money market accounts, and certificates of deposit. The company also provides commercial loans for general corporate purposes comprising financing for working capital, internal growth, and acquisitions, as well as financing for business insurance premiums; real estate term and construction loans; mortgage warehouse lending; mortgage correspondent aggregation; equipment finance and leasing; treasury management services, including online banking and debit and credit card services; escrow services; and letters of credit. In addition, it offers personal wealth management and trust services; secured and unsecured loans; and online and mobile banking services. Further, the company provides American Airlines AAdvantage, an all-digital branch offering depositors. It operates in Austin, Fort Worth, Dallas, Houston, and San Antonio metropolitan areas of Texas. Texas Capital Bancshares, Inc. was founded in 1996 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Texas Capital Bancshares has a trailing twelve months EPS of $6.79.
PE Ratio
Texas Capital Bancshares has a trailing twelve months price to earnings ratio of 9.46. Meaning, the purchaser of the share is investing $9.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.02%.
Yearly Top and Bottom Value
Texas Capital Bancshares’s stock is valued at $64.26 at 16:22 EST, under its 52-week high of $69.27 and way above its 52-week low of $42.79.
Sales Growth
Texas Capital Bancshares’s sales growth is 5.7% for the current quarter and 9.6% for the next.
Volume
Today’s last reported volume for Texas Capital Bancshares is 207026 which is 54.15% below its average volume of 451577.
8. U.S. Physical Therapy (USPH)
6.4% sales growth and 9.08% return on equity
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Earnings Per Share
As for profitability, U.S. Physical Therapy has a trailing twelve months EPS of $2.16.
PE Ratio
U.S. Physical Therapy has a trailing twelve months price to earnings ratio of 55. Meaning, the purchaser of the share is investing $55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.08%.
Sales Growth
U.S. Physical Therapy’s sales growth is 7.4% for the current quarter and 6.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 564.19M for the twelve trailing months.
